Key facts
- Notable investors include NextGen Venture Partners.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Pathway Drugs
- ·The full record, as it builds
Funding rounds
No funding rounds for Pathway Drugs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pathway Drugs
Developer of supply chain technology intended to provide patients access to cost-effective prescription drugs. The company is currently operating in Stealth mode.
- Sector
- Consumer Products and Services (B2C)
- HQ
- San Francisco, CA, United States
- Website
- pathwaydrugs.com/
- Ownership
- Privately Held (backing)
Pathway Drugs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pathway Drugs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pathway Drugs in its N-PORT filings yet. We sweep new filings monthly.